Methyl 2-(nonylideneamino)benzoate
| Common Name: |
Methyl 2-(nonylideneamino)benzoate |
| IUPAC Name: |
methyl 2-(nonylideneamino)benzoate |
| Molecular Formula: |
C17H25NO2 |
| SMILES: |
CCCCCCCCC=NC1=CC=CC=C1C(=O)OC |
| Inchi: |
1S/C17H25NO2/c1-3-4-5-6-7-8-11-14-18-16-13-10-9-12-15(16)17(19)20-2/h9-10,12-14H,3-8,11H2,1-2H3 |
| Inchi Key: |
KRMRLVKJOSLHQF-UHFFFAOYSA-N |
| Cas No: |
72894-12-3 |
| Name |
Value |
| Lipinski Violations |
0 |
| Ghose Violations |
0 |
| Veber Violations |
0 |
| Egan Violations |
0 |
| Muegge Violations |
0 |
| Name |
Value |
| Molecular Weight (g/mol) |
275.39 |
| Mass (g/mol) |
275.189 |
| Molar Refractivity |
85.39 |
| Net Charge |
|
| HBD |
|
| HBA |
3 |
| Rt Bonds |
10 |
| Rings |
1 |
| TPSA |
38.66 |
| Hetero Atoms |
3 |
| Heavy Atoms |
20 |
| Aromatic Heavy Atoms |
6 |
| Melting Point (°C) |
|
| Boiling Point (°C@760.00mm Hg) |
399.00 to 400.00 |
| Vapor Pressure (mmHg@25.00 °C) |
0.000001 |
| Vapor Density (Air =1) |
|
| Fraction Csp3 |
0.53 |
| LogP |
4.926 |
| iLOGP |
3.63 |
| XLOGP3 |
4.95 |
| WLOGP |
4.93 |
| MLOGP |
3.71 |
| ESOL Log S |
-4.23 |
| ESOL Solubility (mg/ml) |
0.016 |
| ESOL Solubility (mol/l) |
0 |
| ESOL Class: esol_class |
Moderately soluble |
| Ali Log S |
-5.50 |
| Ali Solubility (mg/ml) |
0 |
| Ali Solubility (mol/l) |
0 |
| Ali Class |
Moderately soluble |
| Silicos-IT LogSw |
-5.79 |
| Silicos-IT Solubility (mg/ml) |
0 |
| Silicos-IT Solubility (mol/l) |
0 |
| Silicos-IT Class |
Moderately soluble |
| Name |
Value |
| GI Absorption |
High |
| BBB Permeable |
1 |
| PgP Substrate |
0 |
| Log Kp (cm/s) |
-4.47 |
| Bioavailability Score |
0.55 |
| Caco2 |
1 |
| Human Intestinal Absorption |
1 |
| Plasm Protein Binding |
0.992 |
| CYP1A2 Inhibitor |
1 |
| CYP2C19 Inhibitor |
0 |
| CYP2C9 Inhibitor |
0 |
| CYP2D6 inhibitor |
0 |
| CYP3A4 inhibitor |
0 |
| Ames mutagenesis |
0 |
| Acute Oral Toxicity |
1.675 |
| Carcinogenicity (Binary) |
0 |
| Carcinogenicity (Trinary) |
Non-required |
| Eye Irritation |
1 |
| Hepatotoxicity |
0 |
| Androgen Receptor Binding |
0 |
| Aromatase Binding |
1 |
| Estrogen Receptor Binding |
1 |
| Glucocorticoid Receptor Binding |
0 |
| Thyroid Receptor Binding |
1 |
| BRCP inhibitor |
0 |
| BSEP inhibitor |
0 |
| OATP1B1 inhibitor |
1 |
| OATP1B3 inhibitor |
1 |
| OATP2B1 inhibitor |
0 |
| OCT1 inhibitor |
0 |
| OCT2 inhibitor |
0 |
